Cash & equivalents decreased 85.8%
Cash & equivalents changed -85.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -85.8% from the comparable as-filed period.
Gross margin changed -731 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed -40.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -1764.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -665.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -1963 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Stock-based compensation changed +84.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +10.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed -10.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +9.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.